The document is an intimation of a scheduled Analyst/Investor Meeting, filed as a regulatory compliance under SEBI LODR Regulations.
The event is a one-on-one meeting with a specific institutional investor, TATA AIG.
The meeting is scheduled for Monday, June 15, 2026, and will be held virtually.
The meeting time is from 04:30 P.M. to 05:15 P.M. IST.
The stated purpose of the meeting is not explicitly detailed in the intimation beyond being a meeting with an analyst/institutional investor.
The intimation includes a note that the meeting is subject to changes due to exigencies.
Management participants are not listed in this specific disclosure.
The company has provided a link to a presentation document titled STARHEALTH29042026111712ECPresentationQ4FY26V2.pdf, which appears to be from a previous earnings call (Q4 FY26). This presentation will be made available for the meeting and is hosted on the NSE archives.
The disclosure will also be available on the company's website at www.starhealth.in.
The letter is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, indicating it is an official compliance filing. The document does not contain any statement regarding the sharing or non-sharing of Unpublished Price Sensitive Information (UPSI).
Additional Notes Section
The document reference number is SHAI/B & S/SE/38/2026-27.
The intimation was dated and signed on 10th June 2026 from Chennai.
The provided link points to an attachment, specifically an earnings presentation deck from a prior period (Q4 FY26).
No new financial data, guidance, or strategic updates were disclosed in this announcement; it is purely a scheduling intimation.
Logistical details like dial-in numbers are not included, as the meeting is virtual and access is presumably provided directly to the participant.
